Medical News

RSS

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Cannabis Science Inc. (OTCBB: CBIS), an emerging pharmaceutical cannabis company is pleased to announce that the company has signed an agreement with Leading Points Corporation to represent its products, services and initiatives to various government and military agencies.

31 Aug 2009

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

Sonomax Hearing Healthcare Inc. (SHH:TSX Venture Exchange) is proud to announce that it has successfully passed its Phase II milestone, proof-of-performance of a delivery mechanism that inflates a V3 earplug as per fit function criteria.

31 Aug 2009

New director appointed at the Saint John’s Neuroscience Institute

Saint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassam, MD, as Director of the new Saint John’s Neuroscience Institute and faculty member of the John Wayne Cancer Institute at Saint John’s. Dr. Kassam will lead the development of the new Neuroscience Institute which will offer an international minimally invasive neurosurgery center, as well as neuro-oncology, neuro-vascular surgery and other neuroscience services.

31 Aug 2009

Takeda visits managed care professionals to promote its two new drugs

According to SDI, a leading healthcare market insight and analytics firm, in spring 2009, Takeda made more visits to managed care professionals than any other pharmaceutical manufacturer, accounting for almost 7% of contacts recorded in SDI’s Managed Care Pharmacy Executive and Managed Care Medical Director audits.

31 Aug 2009

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

PsychoGenics Inc. and AstraZeneca have entered into a drug discovery and development agreement to identify compounds that are likely to be useful for the treatment of certain Central Nervous System (CNS) disorders.

31 Aug 2009

eClinicalWorks to provide its EMR solution to correctional facilities affiliated with CMS

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that the company has entered into an agreement with Correctional Medical Services, Inc. (CMS), a leading provider of health services for prisons and jails nationwide for over 30 years, to provide its electronic medical records (EMR) solution to correctional facilities affiliated with CMS.

31 Aug 2009

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that it has entered into an agreement with Protein Production Services Ltd. (PPS), a leading manufacturing contractor, in order to start Good Manufacturing Practice (cGMP) production of its stem cell therapeutic product.

31 Aug 2009

The GEO Group acquires Just Care

The GEO Group (NYSE:GEO) (“GEO”), a world leader in the delivery of correctional, detention, and mental health services, announced today that its mental health subsidiary, GEO Care, Inc. (“GEO Care”), has signed a definitive agreement to acquire Just Care, Inc. (“Just Care”), a provider of detention healthcare focusing on the delivery of medical and mental health services, for approximately $40.0 million.

31 Aug 2009

Mark Farrah Associates partners with Strenuus to launch Medicare Benefits Analyzer

Mark Farrah Associates (MFA) announces the addition of Medicare Benefits Analyzer to its online product portfolio. “We are very pleased to be partnering with Strenuus to launch this new product.

31 Aug 2009

Highest Growth Potential Award given to Sundia MediTech Company

Sundia MediTech Company, a leading pharmaceutical R&D outsourcing Service Company in China, announced today that it received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26.

31 Aug 2009

Geron to present updates on product development programs at four investor conferences in September

Geron Corporation today announced that the company will present updates of its product development programs at four investor conferences in the month of September.

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

Holistic health expert highlights the benefits of regular meditatation

Medical costs this year are hitting almost everyone in the pocketbook. With politicians scrambling to come up with a workable solution, Americans face dark days ahead as monthly insurance fees go up again, often with double-digit rate hikes. Is there any hope for hard-working Americans who face the challenge of paying these exorbitant fees?

31 Aug 2009

DYSlipidemia International Study results presented at the ESC congress

According to a new analysis of 22,000 patients, nearly three-quarters of patients taking statins still had at least one lipid abnormality. These results, from a study conducted by Merck & Co., Inc., Whitehouse Station, N.J., U.S.A., which operates in many countries as Merck Sharp & Dohme Limited, were presented today at the European Society of Cardiology (ESC) congress in Barcelona, Spain.

31 Aug 2009

Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference

Tianyin Pharmaceutical Co. Inc., a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced that it will present at the Rodman & Renshaw Annual Global Investment Conference, to be held September 9-11, 2009, at the New York Palace Hotel in New York City.

31 Aug 2009

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

POZEN Inc. (NASDAQ:POZN), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for VIMOVO™ (enteric-coated naproxen / immediate release esomeprazole magnesium, formerly know as PN 400).

31 Aug 2009

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

CVS/pharmacy, the nation's leading retail pharmacy, and MinuteClinic, the largest retail health care clinic provider in the U.S., today announced the availability of seasonal flu vaccinations and urged Americans to protect themselves early against the flu. CVS/pharmacy and MinuteClinic are divisions of CVS Caremark (NYSE: CVS), the largest provider of prescriptions in the country.

31 Aug 2009

HOYA Conbio to feature premium dental lasers at LVI Global's first branch in Brisbane

HOYA ConBio, a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI) Global, an internationally renowned provider of post-graduate dental education, to feature premium dental lasers at LVI Global's first branch in Brisbane, Australia. Effective November 1, this new partnership builds on HOYA ConBio's long-standing involvement at LVI Global's headquarters in Las Vegas.

31 Aug 2009

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPass' proprietary MicronJet microneedle technology for the intradermal delivery of products against a number of diseases including tuberculosis, HIV, malaria, leishmaniasis and leprosy, among others. The financial details of the agreement are confidential.

31 Aug 2009

First Edition: August 31, 2009

Today's headlines hint that summer's almost over, but the heat will still be on for health reform.

31 Aug 2009

Medical News

Cannabis Science enters into an agreement with Leading Points to represent its products to various government and military agencies

Sonomax Hearing Healthcare completes Phase II trials of a delivery mechanism that inflates a V3 earplug successfully

New director appointed at the Saint John’s Neuroscience Institute

Takeda visits managed care professionals to promote its two new drugs

Psychogenics and Astrazeneca sign agreement to identify new compounds for treating Central Nervous System disorders

eClinicalWorks to provide its EMR solution to correctional facilities affiliated with CMS

BrainStorm Cell Therapeutics partners with Protein Production to start production of clinical-grade stem cell therapeutic product

The GEO Group acquires Just Care

Mark Farrah Associates partners with Strenuus to launch Medicare Benefits Analyzer

Highest Growth Potential Award given to Sundia MediTech Company

Geron to present updates on product development programs at four investor conferences in September

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Holistic health expert highlights the benefits of regular meditatation

DYSlipidemia International Study results presented at the ESC congress

Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference

New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration

Seasonal flu shots to be available daily without an appointment at more than 500 MinuteClinic locations

HOYA Conbio to feature premium dental lasers at LVI Global's first branch in Brisbane

IDRI signs agreement to use NanoPass' MicronJet microneedle technology for intradermal vaccines

First Edition: August 31, 2009

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News